Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Oral Anticoagulation in Patients With Liver Disease
HTML
PDF
Details
Locations
Year:
2018
Type:
review
Source:
Journal of the American College of Cardiology
DOI:
10.1016/j.jacc.2018.03.023
Authors:
Arman Qamar,
Muthiah Vaduganathan,
Norton J. Greenberger,
Robert P. Giugliano
Institutions:
Brigham and Women's Hospital,
Harvard University,
Thrombolysis in Myocardial Infarction Study Group
Language:
English
Topic:
Atrial Fibrillation Management and Outcomes
Subfield:
Cardiology and Cardiovascular Medicine
Field:
Medicine
Domain:
Health Sciences
Keywords:
oral anticoagulation,
liver disease,
liver dysfunction,
warfarin,
direct oral anticoagulants,
atrial fibrillation,
venous thromboembolism,
thrombosis,
bleeding complications,
pharmacokinetics,
anticoagulation management
show all 11
SDG:
Good health and well-being
Open Access status:
bronze
Funders:
Bristol-Myers Squibb,
Pfizer,
American College of Cardiology Foundation,
Daiichi-Sankyo,
National Heart, Lung, and Blood Institute
Award:
Training Grant in Cardiovascular Research
OpenAlex ID:
W2802816738
FWCI:
4.046
Cites:
76
Cited by:
200
Related to:
10